Alpha-fetoprotein (AFP)

Alpha-fetoprotein (AFP) and its role in the hormonal panel and prenatal diagnosis. Starting in the second trimester of pregnancy, women and their supra-biblical fetuses experience a number of changes that may be important for the health and development of the baby. One of the most important components in prenatal diagnosis, at the moment, is the hormonal panel, which includes the determination of alpha-fetoprotein (AFP) levels.

Alpha-fetoprotein (AFP) is a protein produced by the baby's liver during pregnancy. AFP levels can be measured through a simple blood test in the mother. This test is usually performed between the 16th and 20th week of pregnancy and is part of the prenatal biochemical screening.

The main purpose of measuring AFP levels is to identify possible abnormalities in fetal development. A low AFP level may indicate a risk of genetic abnormalities, such as Down syndrome or spinal muscular atrophy. Conversely, an elevated AFP level may be a sign of possible problems, such as an open neural tube defect or ventriculomegaly.

It is important to note that elevated AFP levels are not a definitive diagnosis, but only an indicator of risk. If abnormalities are found, further diagnostics such as ultrasound or amniocentesis may be recommended to accurately assess the condition of the fetus.

After determining AFP levels, other components of the hormonal panel, such as beta-chorionic gonadotropin (bCHG) and estriol, also help assess the risk of fetal malformations. When combined with other clinical and imaging methods of diagnosis, the hormonal panel becomes a powerful tool for detecting possible abnormalities and making important decisions about the further management of the pregnancy.

Prenatal biochemical screening, including AFP levels, provides parents with a more accurate understanding of the condition and development of their unborn child. It helps doctors identify potential problems in time and take the necessary measures to support the health of the fetus and mother.

Ukrainian medicine actively uses prenatal biochemical screening, including AFP levels, to improve the quality and accessibility of prenatal diagnostics. It helps parents to approach the pregnancy process in a more informed way and prepare for possible challenges.

All things considered, determining alpha-fetoprotein levels is an important component of the hormonal panel in prenatal diagnostics. It allows you to identify possible abnormalities in fetal development and take timely measures to maintain the health of the unborn child. This approach helps parents to experience the pregnancy period more calmly and prepare for the birth of a healthy baby.